Company / Current Liabilities
Beam Therapeutics Inc. Current Liabilities History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$96.9M
FY2025
5-year range
$96.9M / $223.6M
FY2021-FY2025
Trend
-46.8%
vs FY2024
Sector context
#96 of 213
Health Care
What the data says
At $97M, Beam Therapeutics Inc.'s current liabilities ranks #118 of 213 in the Health Care sector. Current Liabilities has declined for 3 consecutive years, from $224M in FY2022 to $97M in FY2025.
Based on SEC 10-K filings.
$97M in FY2025 with a 5-year CAGR of -1.1%.
Improved from $206M to $97M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -24.3%
- 5-Year CAGR
- -1.1%
- 10-Year CAGR
- -
Sector benchmark
#118 of 213 in Health CareTop 55% of 213This company $96.9M Sector average $1.6B
▼
-93.9% below sector average
Key checks
Key Insights
- Beam Therapeutics Inc.'s current liabilities has declined for 3 consecutive years.
- 5-year CAGR of -1.1%, indicating a declining trend.
- In FY2025, current liabilities decreased 46.8% year-over-year.
- Ranks #96 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $96.9M | -46.8% |
| FY2024 | $182.1M | -11.4% |
| FY2023 | $205.6M | -8.1% |
| FY2022 | $223.6M | +4.8% |
| FY2021 | $213.4M | +108.6% |
| FY2020 | $102.3M | +251.2% |
| FY2019 | $29.1M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026